{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:41:44Z","timestamp":1787002904591,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41380-024-02618-1","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T01:02:22Z","timestamp":1723770142000},"page":"547-555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Abatacept inhibits Th17 differentiation and mitigates \u03b1-synuclein-induced dopaminergic dysfunction in mice"],"prefix":"10.1038","volume":"30","author":[{"given":"Julia R.","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Sa","family":"Bacelar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Gripp","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4147-0143","authenticated-orcid":false,"given":"Raquel Costa da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia S.","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata V.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia F.","family":"Valad\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel S.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuelle V.","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian C.","family":"Colodeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5076-1376","authenticated-orcid":false,"given":"Luana C.","family":"Mangeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalgisa","family":"Wiecikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita N.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heitor A.","family":"Paula-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4278-212X","authenticated-orcid":false,"given":"Yraima","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3368-2878","authenticated-orcid":false,"given":"Giselle F.","family":"Passos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia P.","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"2618_CR1","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T. Parkinson\u2019s disease. Lancet Lond Engl. 2009;373:2055\u201366.","journal-title":"Lancet Lond Engl"},{"key":"2618_CR2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet Lond Engl. 2015;386:896\u2013912.","journal-title":"Lancet Lond Engl"},{"key":"2618_CR3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. \u03b1-Synuclein in Lewy bodies. Nature. 1997;388:839\u201340.","journal-title":"Nature"},{"key":"2618_CR4","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the \u03b1-Synuclein Gene Identified in Families with Parkinson\u2019s Disease. Science. 1997;276:2045\u20137.","journal-title":"Science"},{"key":"2618_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","volume":"46","author":"M Sharma","year":"2023","unstructured":"Sharma M, Burr\u00e9 J. \u03b1-Synuclein in synaptic function and dysfunction. Trends Neurosci. 2023;46:153\u201366.","journal-title":"Trends Neurosci"},{"key":"2618_CR6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 2009;8:382\u201397.","journal-title":"Lancet Neurol"},{"key":"2618_CR7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA\u2010DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38:1285\u201391.","journal-title":"Neurology"},{"key":"2618_CR8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/exnr.2002.7960","volume":"177","author":"E Rousselet","year":"2002","unstructured":"Rousselet E, Callebert J, Parain K, Joubert C, Hunot S, Hartmann A, et al. Role of TNF-\u03b1 Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP. Exp Neurol. 2002;177:183\u201392.","journal-title":"Exp Neurol"},{"key":"2618_CR9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Tumor necrosis factor-\u03b1 (TNF-\u03b1) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett. 1994;165:208\u201310.","journal-title":"Neurosci Lett"},{"key":"2618_CR10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22:657\u201373.","journal-title":"Nat Rev Immunol"},{"key":"2618_CR11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, et al. T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature. 2017;546:656\u201361.","journal-title":"Nature"},{"key":"2618_CR12","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15626-w","volume":"11","author":"CS Lindestam Arlehamn","year":"2020","unstructured":"Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, et al. \u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat Commun. 2020;11:1875.","journal-title":"Nat Commun"},{"key":"2618_CR13","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest. 2009;119:182\u201392.","journal-title":"J Clin Invest"},{"key":"2618_CR14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-5728(00)00422-7","volume":"113","author":"Bas","year":"2001","unstructured":"Bas, Calopa J, Mestre M, Mollev\u00ed DG M, Cutillas B, Ambrosio S, et al. Lymphocyte populations in Parkinson\u2019s disease and in rat models of parkinsonism. J Neuroimmunol. 2001;113:146\u201352.","journal-title":"J Neuroimmunol"},{"key":"2618_CR15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","volume":"11","author":"Y Baba","year":"2005","unstructured":"Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T. Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord. 2005;11:493\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"2618_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.08.002","volume":"169","author":"Z Chen","year":"2018","unstructured":"Chen Z, Chen S, Liu J. Prog Neurobiol. 2018;169:1\u201323.","journal-title":"Prog Neurobiol"},{"key":"2618_CR17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","volume":"7","author":"JAH Saunders","year":"2012","unstructured":"Saunders JAH, Estes KA, Kosloski LM, Allen HE, Dempsey KM, Torres-Russotto DR, et al. CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol. 2012;7:927\u201338.","journal-title":"J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol"},{"key":"2618_CR18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2022.10.023","volume":"108","author":"J Li","year":"2023","unstructured":"Li J, Zhao J, Chen L, Gao H, Zhang J, Wang D, et al. \u03b1-Synuclein induces Th17 differentiation and impairs the function and stability of Tregs by promoting RORC transcription in Parkinson\u2019s disease. Brain Behav Immun. 2023;108:32\u201344.","journal-title":"Brain Behav Immun"},{"key":"2618_CR19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","volume":"67","author":"S Theodore","year":"2008","unstructured":"Theodore S, Cao S, McLean PJ, Standaert DG. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol. 2008;67:1149\u201358.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2618_CR20","volume":"17","author":"M Iba","year":"2020","unstructured":"Iba M, Kim C, Sallin M, Kwon S, Verma A, Overk C, et al. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and \u03b1-synuclein transgenic models. J Neuroinflammation. 2020;17:214.","journal-title":"J Neuroinflammation"},{"key":"2618_CR21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2022.01.007","volume":"101","author":"AA Karikari","year":"2022","unstructured":"Karikari AA, McFleder RL, Ribechini E, Blum R, Bruttel V, Knorr S, et al. Neurodegeneration by \u03b1-synuclein-specific T cells in AAV-A53T-\u03b1-synuclein Parkinson\u2019s disease mice. Brain Behav Immun. 2022;101:194\u2013210.","journal-title":"Brain Behav Immun"},{"key":"2618_CR22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbr.2017.06.047","volume":"333","author":"JTS Fortuna","year":"2017","unstructured":"Fortuna JTS, Gralle M, Beckman D, Neves FS, Diniz LP, Frost PS, et al. Brain infusion of \u03b1-synuclein oligomers induces motor and non-motor Parkinson\u2019s disease-like symptoms in mice. Behav Brain Res. 2017;333:150\u201360.","journal-title":"Behav Brain Res"},{"key":"2618_CR23","doi-asserted-by":"crossref","first-page":"168011","DOI":"10.1016\/j.jmb.2023.168011","volume":"435","author":"RWL So","year":"2023","unstructured":"So RWL, Watts JC. \u03b1-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases. J Mol Biol. 2023;435:168011.","journal-title":"J Mol Biol"},{"key":"2618_CR24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S. Parkinson\u2019s disease: mechanisms and models. Neuron. 2003;39:889\u2013909.","journal-title":"Neuron"},{"key":"2618_CR25","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain J Neurol. 2021;144:2047\u201359.","journal-title":"Brain J Neurol"},{"key":"2618_CR26","first-page":"4137","volume":"182","author":"AD Reynolds","year":"2009","unstructured":"Reynolds AD, Stone DK, Mosley RL, Gendelman HE. J Immunol Baltim Md 1950. 2009;182:4137\u201349.","journal-title":"J Immunol Baltim Md 1950"},{"key":"2618_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, et al. Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients. J Neuroinflammation. 2018;15:205.","journal-title":"J Neuroinflammation"},{"key":"2618_CR28","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar2416","volume":"10","author":"MH Buch","year":"2008","unstructured":"Buch MH, Vital EM, Emery P. Abatacept in the treatment of rheumatoid arthritis. Arthritis Res Ther. 2008;10:S5.","journal-title":"Arthritis Res Ther"},{"key":"2618_CR29","first-page":"1373","volume":"202","author":"S Glatigny","year":"2019","unstructured":"Glatigny S, H\u00f6llbacher B, Motley SJ, Tan C, Hundhausen C, Buckner JH, et al. J Immunol Baltim Md 1950. 2019;202:1373\u201382.","journal-title":"J Immunol Baltim Md 1950"},{"key":"2618_CR30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd3877","volume":"12","author":"S Yao","year":"2013","unstructured":"Yao S, Zhu Y, Chen L. Advances in targeting cell surface signalling molecules for immune modulation. Nat Rev Drug Discov. 2013;12:130\u201346.","journal-title":"Nat Rev Drug Discov"},{"key":"2618_CR31","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","volume":"33","author":"AS Harms","year":"2013","unstructured":"Harms AS, Cao S, Rowse AL, Thome AD, Li X, Mangieri LR, et al. J Neurosci Off J Soc Neurosci. 2013;33:9592\u2013600.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2618_CR32","doi-asserted-by":"crossref","first-page":"300060521998471","DOI":"10.1177\/0300060521998471","volume":"49","author":"W Li","year":"2021","unstructured":"Li W, Luo Y, Xu H, Ma Q, Yao Q. Refractory primary extramedullary plasmacytoma in kidney: a case report. J Int Med Res. 2021;49:300060521998471.","journal-title":"J Int Med Res"},{"key":"2618_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D. \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med. 2017;23:1\u201313.","journal-title":"Nat Med"},{"key":"2618_CR34","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1007\/s00415-023-11635-z","volume":"270","author":"E Contaldi","year":"2023","unstructured":"Contaldi E, Magistrelli L, Furgiuele A, Gallo S, Comi C. Relationship between [123I]FP-CIT SPECT data and peripheral CD4+ T cell profile in newly-diagnosed drug-na\u00efve Parkinson\u2019s disease patients. J Neurol. 2023;270:2776\u201383.","journal-title":"J Neurol"},{"key":"2618_CR35","doi-asserted-by":"crossref","first-page":"e1376","DOI":"10.1371\/journal.pone.0001376","volume":"3","author":"EJ Benner","year":"2008","unstructured":"Benner EJ, Banerjee R, Reynolds AD, Sherman S, Pisarev VM, Tsiperson V, et al. Nitrated \u03b1\u2013Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons. PloS One. 2008;3:e1376.","journal-title":"PloS One"},{"key":"2618_CR36","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-014-0201-8","volume":"11","author":"H Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez H, Pacheco R. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation. 2014;11:201.","journal-title":"J Neuroinflammation"},{"key":"2618_CR37","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1636-8","volume":"16","author":"RH Earls","year":"2019","unstructured":"Earls RH, Menees KB, Chung J, Barber J, Gutekunst C-A, Hazim MG, et al. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice. J Neuroinflammation. 2019;16:250.","journal-title":"J Neuroinflammation"},{"key":"2618_CR38","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3390\/cells11182908","volume":"11","author":"B Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S, et al. Neuroinflammation and Parkinson\u2019s Disease\u2014From Neurodegeneration to Therapeutic Opportunities. Cells. 2022;11:2908.","journal-title":"Cells"},{"key":"2618_CR39","doi-asserted-by":"crossref","unstructured":"Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol. 2010;28:445\u201389.","DOI":"10.1146\/annurev-immunol-030409-101212"},{"key":"2618_CR40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11481-015-9618-9","volume":"10","author":"H Gonz\u00e1lez","year":"2015","unstructured":"Gonz\u00e1lez H, Contreras F, Pacheco R. Regulation of the Neurodegenerative Process Associated to Parkinson\u2019s Disease by CD4+ T-cells. J Neuroimmune Pharmacol. 2015;10:561\u201375.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2618_CR41","doi-asserted-by":"crossref","unstructured":"Reynolds AD, Stone DK, Hutter JAL, Benner EJ, Mosley RL, Gendelman HE. Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease. J Immunol. 2010;184: 2261\u201371.","DOI":"10.4049\/jimmunol.0901852"},{"key":"2618_CR42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer A, Marxreiter F, Krach F, Fadler T, Grosch J, Maroni M, et al. Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson\u2019s Disease. Cell Stem Cell. 2018;23:123\u2013131.e6.","journal-title":"Cell Stem Cell"},{"key":"2618_CR43","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","volume":"81","author":"Z Liu","year":"2019","unstructured":"Liu Z, Qiu A-W, Huang Y, Yang Y, Chen J-N, Gu T-T, et al. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson\u2019s disease. Brain Behav Immun. 2019;81:630\u201345.","journal-title":"Brain Behav Immun"},{"key":"2618_CR44","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.3390\/cells12242808","volume":"12","author":"P Goutakoli","year":"2023","unstructured":"Goutakoli P, Papadaki G, Repa A, Avgoustidis N, Kalogiannaki E, Flouri I, et al. A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients. Cells. 2023;12:2808.","journal-title":"Cells"},{"key":"2618_CR45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1742-7843.2009.00375.x","volume":"104","author":"R Korhonen","year":"2009","unstructured":"Korhonen R, Moilanen E. Abatacept, a novel CD80\/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis. Basic Clin Pharmacol Toxicol. 2009;104:276\u201384.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2618_CR46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaut.2019.04.016","volume":"101","author":"R Lorenzetti","year":"2019","unstructured":"Lorenzetti R, Janowska I, Smulski CR, Frede N, Henneberger N, Walter L, et al. Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. J Autoimmun. 2019;101:145\u201352.","journal-title":"J Autoimmun"},{"key":"2618_CR47","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/cei.12367","volume":"177","author":"A Picchianti Diamanti","year":"2014","unstructured":"Picchianti Diamanti A, Rosado MM, Scarsella M, Germano V, Giorda E, Cascioli S, et al. Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-\u03b1 agents. Clin Exp Immunol. 2014;177:630\u201340.","journal-title":"Clin Exp Immunol"},{"key":"2618_CR48","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/art.21201","volume":"52","author":"JM Kremer","year":"2005","unstructured":"Kremer JM, Dougados M, Emery P, Durez P, Sibilia J, Shergy W, et al. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2005;52:2263\u201371.","journal-title":"Arthritis Rheum"},{"key":"2618_CR49","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775\u201387.","journal-title":"Cell"},{"key":"2618_CR50","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11481-019-09888-5","volume":"15","author":"Y Huang","year":"2020","unstructured":"Huang Y, Liu Z, Cao B-B, Qiu Y-H, Peng Y-P. Treg Cells Attenuate Neuroinflammation and Protect Neurons in a Mouse Model of Parkinson\u2019s Disease. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol. 2020;15:224\u201337.","journal-title":"J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol"},{"key":"2618_CR51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463:3\u201333.","journal-title":"Eur J Pharmacol"},{"key":"2618_CR52","doi-asserted-by":"crossref","first-page":"1202160","DOI":"10.3389\/fimmu.2023.1202160","volume":"14","author":"G Carvajal Alegria","year":"2023","unstructured":"Carvajal Alegria G, Nicolas M, van Sleen Y. Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants? Front Immunol. 2023;14:1202160.","journal-title":"Front Immunol"},{"key":"2618_CR53","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2147\/JIR.S316439","volume":"14","author":"L Dong","year":"2021","unstructured":"Dong L, Zheng Y-M, Luo X-G, He Z-Y. High Inflammatory Tendency Induced by Malignant Stimulation Through Imbalance of CD28 and CTLA-4\/PD-1 Contributes to Dopamine Neuron Injury. J Inflamm Res. 2021;14:2471\u201382.","journal-title":"J Inflamm Res"},{"key":"2618_CR54","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/ajt.13704","volume":"16","author":"R Aron Badin","year":"2016","unstructured":"Aron Badin R, Vadori M, Vanhove B, Nerriere-Daguin V, Naveilhan P, Neveu I, et al. Cell Therapy for Parkinson\u2019s Disease: A Translational Approach to Assess the Role of Local and Systemic Immunosuppression. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2016;16:2016\u201329.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"2618_CR55","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/ajt.12600","volume":"14","author":"SM Krummey","year":"2014","unstructured":"Krummey SM, Cheeseman JA, Conger JA, Jang PS, Mehta AK, Kirk AD, et al. High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2014;14:607\u201314.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"2618_CR56","doi-asserted-by":"crossref","unstructured":"Lee J, Lozano-Ruiz B, Yang FM, Fan DD, Shen L, Gonz\u00e1lez-Navajas JM. The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy. Front Immunol. 2021;12. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2021.625667\/full.","DOI":"10.3389\/fimmu.2021.625667"},{"key":"2618_CR57","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1111\/febs.12471","volume":"280","author":"E Coelho-Cerqueira","year":"2013","unstructured":"Coelho-Cerqueira E, Carmo-Gon\u00e7alves P, Pinheiro AS, Cortines J, Follmer C. FEBS J. 2013;280:4915\u201327.","journal-title":"FEBS J"},{"key":"2618_CR58","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jmb.2010.10.027","volume":"405","author":"CA Braga","year":"2011","unstructured":"Braga CA, Follmer C, Palhano FL, Khattar E, Freitas MS, Rom\u00e3o L, et al. The anti-Parkinsonian drug selegiline delays the nucleation phase of \u03b1-synuclein aggregation leading to the formation of nontoxic species. J Mol Biol. 2011;405:254\u201373.","journal-title":"J Mol Biol"},{"key":"2618_CR59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsb.2005.06.006","volume":"151","author":"R Khurana","year":"2005","unstructured":"Khurana R, Coleman C, Ionescu-Zanetti C, Carter SA, Krishna V, Grover RK, et al. Mechanism of thioflavin T binding to amyloid fibrils. J Struct Biol. 2005;151:229\u201338.","journal-title":"J Struct Biol"},{"key":"2618_CR60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11866-7","volume":"10","author":"CP Figueiredo","year":"2019","unstructured":"Figueiredo CP, Barros-Arag\u00e3o FGQ, Neris RLS, Frost PS, Soares C, Souza INO, et al. Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice. Nat Commun. 2019;10:3890.","journal-title":"Nat Commun"},{"key":"2618_CR61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jneumeth.2006.06.001","volume":"158","author":"C Monville","year":"2006","unstructured":"Monville C, Torres EM, Dunnett SB. Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. J Neurosci Methods. 2006;158:219\u201323.","journal-title":"J Neurosci Methods"},{"key":"2618_CR62","doi-asserted-by":"crossref","unstructured":"Fleming SM, Ekhator OR, Ghisays V. Assessment of sensorimotor function in mouse models of Parkinson\u2019s disease. J Vis Exp JoVE. 2013;76:50303.","DOI":"10.3791\/50303"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02618-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02618-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02618-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T14:36:30Z","timestamp":1737383790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02618-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2618"],"URL":"https:\/\/doi.org\/10.1038\/s41380-024-02618-1","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"25 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}